Literature DB >> 8813113

Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.

H J Mauceri1, N N Hanna, J D Wayne, D E Hallahan, S Hellman, R R Weichselbaum.   

Abstract

Intratumoral injection of an adenoviral vector containing radiation-inducible DNA sequences of the Egr-1 promoter linked to a cDNA encoding tumor necrosis factor (TNF) alpha (Ad.Egr-TNF) enhances the tumoricidal action of ionizing radiation in a human epidermoid carcinoma xenograft (SQ-20B). The dominant histopathological feature in tumor-bearing animals treated with Ad.Egr-TNF and irradiation is extensive intratumoral vascular thrombosis and tumor necrosis. Thrombosis and necrosis are not observed in animals treated with either the viral construct encoding TNF-alpha or radiation and did not occur in irradiated normal tissues adjacent to tumor in animals injected with Ad.Egr-TNF. To determine if the occlusive effects of Ad.Egr-TNF and X-irradiation were specific for tumor vessels, non-tumor-bearing mice were irradiated after receiving i.m. injection of Ad.Egr-TNF at viral titers 20-100 times greater than titers injected intratumorally. No vascular thrombosis was observed in the treated normal tissues. Combined Ad.Egr-TNF and radiation produced occlusion of tumor microvessels without significant normal tissue damage. Taken together, these data suggest that the interaction between radiation inducible TNF-alpha and X-irradiation occurs selectively within the tumor vessels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813113

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study.

Authors:  J Randolph Hecht; James J Farrell; Neil Senzer; John Nemunaitis; Alexander Rosemurgy; Theodore Chung; Nader Hanna; Kenneth J Chang; Milind Javle; Mitchell Posner; Irving Waxman; Anthony Reid; Richard Erickson; Marcia Canto; Amitabh Chak; Gretta Blatner; Milan Kovacevic; Mark Thornton
Journal:  Gastrointest Endosc       Date:  2012-02       Impact factor: 9.427

2.  Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.

Authors:  Nathan A Koonce; Charles M Quick; Matthew E Hardee; Azemat Jamshidi-Parsian; Judith A Dent; Giulio F Paciotti; Dmitry Nedosekin; Ruud P M Dings; Robert J Griffin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-26       Impact factor: 7.038

Review 3.  Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.

Authors:  Jason R Baird; Arta M Monjazeb; Omid Shah; Heather McGee; William J Murphy; Marka R Crittenden; Michael J Gough
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-19       Impact factor: 7.038

4.  Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity.

Authors:  Yuli Li; Guobo Shen; Wen Nie; Zhimian Li; Yaxiong Sang; Binglan Zhang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-14       Impact factor: 4.553

5.  Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation of sterol regulatory element binding protein-1 and activation of acetyl CoA carboxylase.

Authors:  Mazhar Al-Zoubi; Galina Chipitsyna; Shivam Saxena; Konrad Sarosiek; Ankit Gandhi; Christopher Y Kang; Daniel Relles; Jocelyn Andrelsendecki; Terry Hyslop; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

6.  Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease.

Authors:  Christina Wu; Soledad A Fernandez; Tamara Criswell; Tarek A Chidiac; Denis Guttridge; Miguel Villalona-Calero; Tanios S Bekaii-Saab
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

7.  Characterization of response to radiation mediated gene therapy by means of multimodality imaging.

Authors:  Chad R Haney; Adrian D Parasca; Xiaobing Fan; Rebecca M Bell; Marta A Zamora; Gregory S Karczmar; Helena J Mauceri; Howard J Halpern; Ralph R Weichselbaum; Charles A Pelizzari
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

8.  Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.

Authors:  Joseph M Herman; Aaron T Wild; Hao Wang; Phuoc T Tran; Kenneth J Chang; Gretchen E Taylor; Ross C Donehower; Timothy M Pawlik; Mark A Ziegler; Hongyan Cai; Dionne T Savage; Marcia I Canto; Jason Klapman; Tony Reid; Raj J Shah; Sarah E Hoffe; Alexander Rosemurgy; Christopher L Wolfgang; Daniel A Laheru
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

9.  In vivo electron paramagnetic resonance imaging of differential tumor targeting using cis-3,4-di(acetoxymethoxycarbonyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl.

Authors:  Gage Redler; Eugene D Barth; Kenneth S Bauer; Joseph P Y Kao; Gerald M Rosen; Howard J Halpern
Journal:  Magn Reson Med       Date:  2013-06-14       Impact factor: 4.668

10.  Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy.

Authors:  Sijumon Kunjachan; Alexandre Detappe; Rajiv Kumar; Thomas Ireland; Lisa Cameron; Douglas E Biancur; Vincent Motto-Ros; Lucie Sancey; Srinivas Sridhar; G Mike Makrigiorgos; Ross I Berbeco
Journal:  Nano Lett       Date:  2015-10-06       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.